Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
Aliment Pharmacol Ther
; 43(1): 114-24, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26503582
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Polyethylene Glycols
/
Membrane Glycoproteins
/
Interferon-alpha
/
Hepatitis C, Chronic
/
Plant Lectins
/
Receptors, N-Acetylglucosamine
/
Liver Cirrhosis
/
Antigens, Neoplasm
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: